Center-Generated Peer-Reviewed Publications

  1. Kancherla V. (2023). Neural tube defects: a review of global prevalence, causes, and primary prevention. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 39(7), 1703–1710.
  2. Madrid, L., Vyas, K. J., Kancherla, V., Leulseged, H., Suchdev, P. S., Bassat, Q., Sow, S. O., El Arifeen, S., Madhi, S. A., Onyango, D., Ogbuanu, I., Scott, J. A. G., Blau, D., Mandomando, I., Keita, A. M., Gurley, E. S., Mahtab, S., Akelo, V., Sannoh, S., Tilahun, Y., … CHAMPS Consortium (2023). Neural tube defects as a cause of death among stillbirths, infants, and children younger than 5 years in sub-Saharan Africa and southeast Asia: an analysis of the CHAMPS network. The Lancet. Global health, 11(7), e1041–e1052.
  3. Kancherla, V., Mowla, S., Räisänen, S., & Gissler, M. (2023). Early Neonatal Mortality among Babies Born with Spina Bifida in Finland (2000-2014). American journal of perinatology, 40(11), 1208–1216.
  4. Kancherla, V., et al. (2022). Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid. The Lancet. Global health, 10(7), e1053–e1057.
  5. Kancherla, V., Botto, L. D., Rowe, L. A., Shlobin, N. A., Caceres, A., Arynchyna-Smith, A., Zimmerman, K., Blount, J., Kibruyisfaw, Z., Ghotme, K. A., Karmarkar, S., Fieggen, G., Roozen, S., Oakley, G. P., Jr, Rosseau, G., & Berry, R. J. (2022). Mandatory food fortification with folic acid – Authors’ reply. The Lancet. Global health, 10(10), e1391–e1392.
  6. Kancherla, V., Wagh, K., Priyadarshini, P., Pachón, H., & Oakley, G. P., Jr (2022). A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2020: 30-Year anniversary of gaining knowledge about folic acid’s prevention potential for neural tube defects. Birth defects research, 114(20), 1392–1403.
  7. Singer, T. G., Kancherla, V., & Oakley, G. (2022). Paediatricians as champions for ending folic acid-preventable spina bifida, anencephaly globally. BMJ paediatrics open, 6(1), e001745.
  8. Kancherla, V., Ma, C., Grant, G., Lee, H. C., Hintz, S. R., & Carmichael, S. L. (2021). Factors Associated with Early Neonatal and First-Year Mortality in Infants with Myelomeningocele in California from 2006 to 2011. American journal of perinatology, 38(12), 1263–1270.
  9. Martinez, H., Pachón, H., Kancherla, V., & Oakley, G. P. (2021). Food Fortification With Folic Acid for Prevention of Spina Bifida and Anencephaly: The Need for a Paradigm Shift in Evidence Evaluation for Policy-Making. American journal of epidemiology, 190(10), 1972–1976.
  10. Kancherla V, Chaddha M, Rowe L, Thompson A, Jain S, Walters D, Martinez H. (2021). Reducing the burden of anemia and neural tube defects in low- and middle-income countries: An analysis to identify countries with an immediate potential to benefit from large-scale mandatory fortification of wheat flour and rice. Nutrients;13(1):244. doi: 10.3390/nu13010244.
  11. Kancherla V, Koning J, Hagos M, Mersha W, Kibruyisfaw Z, Addisalem B, Koning M. (2020). Projected impact of mandatory food fortification with folic acid on nuerosurgical capacity needed for treating spina bifida in Ethiopia. Birth Defects Res. doi: 10.1002/bdr2.1857.
  12. Kancherla V, Wagh K, Pachón H, Oakley GP Jr. (2020). A 2019 global update on folic acid-preventable spina bifida and anencephaly. Birth Defects Res; 113(1):77-89
  13. Kancherla V, Tsang B, Wagh K, Dixon M, Oakley GP Jr. (2020). Modeling shows high potential of folic acid-fortified salt to accelerate global prevention of major neural tube defects. Birth Defects Res;112(18):1461-1474.
  14. Kancherla V, Pachón H, Blencowe H, Martinez H, Oakley GP Jr, Berry RJ. (2020). The fallacy of using administrative data in assessing the effectiveness of food fortification. (2020). Comment on: “Folic Acid Fortification and Neural Tube Defect Risk: Analysis of the Food Fortification Initiative Dataset, Nutrients 2020, 12, 247”Nutrients;12(5):E1352
  15. Dixon M, Kancherla V, Mulugeta A, Magana T, Oakley GP Jr. (2019). High Potential for Reducing Folic Acid-Preventable Spina Bifida and Anencephaly and Related Stillbirth and Child Mortality in Ethiopia. Birth Def Res;111(19):1513-1519
  16. Kancherla V, Averbach H, Oakley GP Jr. (2019). Nation-wide failure of voluntary folic acid fortification of corn masa flour and tortillas with folic acid. Birth Defects Res;111(11):672-675
  17. Redpath B, Kancherla V, Oakley GP. Availability of corn masa flour and tortillas fortified with folic acid in Atlanta after national regulations allowing voluntary fortification. JAMA. 2018;320(15):1600-1601.
  18. Kancherla V, Wagh K, Johnson Q, Oakley GP Jr. (2018). 2017 Status of global prevention of folic acid-preventable spina bifida and anencephaly. Birth Def Res;110(14):1139-1147.
  19. Kancherla V, Redpath B, Oakley GP Jr. (2018). Reductions in child mortality by preventing spina bifida and anencephaly – Implications in achieving Target 3.2 of the Sustainable Development Goals in countries with immediate potential for folic acid fortification. Birth defects research, 111(14), 958–966.
  20. Kancherla V. (2018). Countries with an immediate potential for primary prevention of spina bifida and anencephaly through mandatory fortification of wheat flour with folic acid. Birth Defects Res;110(11):956-965
  21. Kancherla V, Black R. (2018). A historical perspective and challenges in estimation of global prevalence of neural tube defects. Ann NY Acad Sci;1414(1):20-30
  22. Blencowe H, Kancherla V, Moorthie S, Darlison M, Gibbons S, Modell B. (2018). Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann NY Acad Sci; 1414(1):31-46.
  23. Kancherla V, Hasan MOS, Hamid R, Oakley GP Jr., Rahman M, Quamruzzaman Q, Mazumdar M. (2017). Prenatal folic acid use associated with decreased risk of myelomeningocele: Further support for folic acid fortification in Bangladesh. PLoS One 30;12(11):e0188726
  24. Kancherla V, Oakley GP Jr. (2017). Total prevention of folic acid-preventable spina bifida and anencephaly would reduce child mortality in India – Implications in achieving Target 3.2 of the Sustainable Development Goals. Birth Defects Res;110(5):421-428
  25. Kancherla V, Weakland A, Walani S, Bauwens L, Warf B, Oakley GP Jr. (2017). Scorecard for spina bifida research, prevention, and policy – A development process. Prev Med;99:13-20.
  26. Kancherla V, Elliott JL Jr, Patel BB, Holland NW, Johnson TM 2nd, Khakharia A, Phillips LS, Oakley GP Jr., Vaughan CP. (2017). Long-term metformin therapy and monitoring for vitamin B-12 deficiency among older Veterans. J Am Geriatric Soc;65(5):1061-1066.
  27. Mukhtar A, Kramer MR, Oakley GP Jr., Kancherla V. (2017). Race and Ethnicity and preconceptional folic acid supplement use among women of reproductive age in Georgia, PRAMS 2009 to 2011. Birth Defects Res Part A Clin Mol Teratol;109(1):38-48.
  28. Kancherla V, Garn J, Zakai NA, Williamson RS, Cashion WT, Oluwaseun O, Judd S, McClellan W, Oakley GP Jr. (2016). Multivitamin use and serum vitamin B-12 levels in older-adult metformin users in REGARDS, 2003-2007. PLoS One;11(8):p.e0160802.
  29. Arth A, Kancherla V, Pachón H, Zimmerman S, Johnson Q, Oakley GP Jr. (2016). Status of global prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol;106(7):520-9.
  30. Oakley GP Jr., Kancherla V. (2016). Will the Eastern Mediterranean Region be the first to prevent all of folic acid preventable-spina bifida and anencephaly? Saudi Med J;37(1):10-11.
  31. Obeid R, Pietrzik K, Oakley GP Jr., Kancherla V, Holzgreve W, Wieser S. (2015). Preventable neural tube defects in Europe. Birth Defects Res A Clin Mol Teratol;103(9):763-71.
  32. Kancherla V, Druschel CM, Oakley GP Jr. (2014). A population-based study to investigate mortality in spina bifida – New York State Congenital Malformations Program. Birth Defects Res A Clin Mol Teratol;100(8):563-75.
  33. Kancherla V, Oakley GP Jr., Brent RL. (2013). Urgent global opportunities to prevent birth defects. Semin Fetal Neonatal Med;19(3):153-60.
  34. Youngblood M, Williamson R, Bell KN, Johnson Q, Kancherla V, Oakley GP Jr. (2013). A 2012 Update on Global Prevention of Folic Acid-Preventable Spina Bifida and Anencephaly. Birth Defects Res A Clin Mol Teratol;97(10):658-63.
  35. Pachon H, Kancherla V, Handforth B, Tyler V, Bauwens L (2013). Folic-acid fortification of wheat flour:  A cost-effective public-health intervention to prevent birth defects in Europe. Nutrition Bulletin;38:201-09.